Riverain Medical Group

Riverain Technologies is a clinical AI company focused on improving the detection of lung disease through advanced thoracic imaging software. The company's ClearRead platform utilizes patented machine learning technology to suppress "noise" in medical images, such as bones in X-rays or vessels in CT scans, allowing radiologists to see nodules and other pathologies more clearly. Its suite of FDA-cleared products, including ClearRead CT and ClearRead Xray, are designed to enhance diagnostic accuracy and streamline clinical workflows. By facilitating earlier detection of lung cancer, Riverain aims to improve patient outcomes and survival rates. The company is headquartered in Miamisburg, Ohio, and its solutions are utilized by leading healthcare systems worldwide.